These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 10484017

  • 1. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H, Nakaizumi A, Tatsuta M, Baba M, Takenaka A, Uedo N, Sakai N, Yano H, Iishi H, Ohigashi H, Ishikawa O, Okada S, Kakizoe T.
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
    Uehara H, Nakaizumi A, Baba M, Iishi H, Tatsuta M, Kitamura T, Ohigashi H, Ishikawa O, Takenaka A, Ishiguro S.
    Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K, Suda T, Aoyagi Y, Sugawara S, Natsui M, Motoyama H, Shirai Y, Sekine T, Kawai H, Mita Y, Waguri N, Kuroiwa T, Igarashi M, Asakura H.
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [Abstract] [Full Text] [Related]

  • 4. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y, Watanabe H, Yrdiran S, Ohtsubo K, Motoo Y, Okai T, Sawabu N.
    Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
    [Abstract] [Full Text] [Related]

  • 5. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.
    Lu X, Xu T, Qian J, Wen X, Wu D.
    Chin Med J (Engl); 2002 Nov; 115(11):1632-6. PubMed ID: 12609076
    [Abstract] [Full Text] [Related]

  • 6. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M, Müller P, Mora J, Brinkmann B, Ostwald C, Farré A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capellá G, Liebe S.
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [Abstract] [Full Text] [Related]

  • 7. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Uehara H, Nakaizumi A, Iishi H, Takenaka A, Eguchi H, Ohigashi H, Ishikawa O.
    Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
    [Abstract] [Full Text] [Related]

  • 8. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
    Lu X, Xu T, Qian J.
    Zhonghua Yi Xue Za Zhi; 2001 Sep 10; 81(17):1050-3. PubMed ID: 11758254
    [Abstract] [Full Text] [Related]

  • 9. Genetic diagnosis of pancreatic cancer.
    Mizumoto K, Tanaka M.
    J Hepatobiliary Pancreat Surg; 2002 Sep 10; 9(1):39-44. PubMed ID: 12021896
    [Abstract] [Full Text] [Related]

  • 10. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K, Mizumoto K, Ishikawa N, Sato N, Nagai E, Yamaguchi K, Takaishi H, Ide T, Tanaka M.
    Cancer; 2004 Nov 15; 101(10):2309-17. PubMed ID: 15476274
    [Abstract] [Full Text] [Related]

  • 11. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
    Myung SJ, Kim MH, Kim YS, Kim HJ, Park ET, Yoo KS, Lim BC, Wan Seo D, Lee SK, Min YI, Kim JY.
    Gastrointest Endosc; 2000 Jun 15; 51(6):708-13. PubMed ID: 10840305
    [Abstract] [Full Text] [Related]

  • 12. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ.
    Cancer Res; 1993 Jun 01; 53(11):2472-4. PubMed ID: 8495407
    [Abstract] [Full Text] [Related]

  • 13. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N, Mizumoto K, Tanaka M, Niiyama H, Yokohata K, Tominaga Y, Shimura H, Muta T, Hamasaki N.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
    Nakaizumi A, Uehara H, Takenaka A, Uedo N, Sakai N, Yano H, Ohigashi H, Ishikawa O, Ishiguro S, Sugano K, Tatsuta M.
    Hepatogastroenterology; 1999 Dec 01; 46(25):31-7. PubMed ID: 10228761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H, Trümper L, Bürger B, Jacobs G, Kriener S, von Blohn G, Zeitz M, Pfreundschuh M.
    Dtsch Med Wochenschr; 1995 Jun 09; 120(23):821-5. PubMed ID: 7781522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.